Inflammatory cytokines, pleuropneumonia infection and the effect of dexamethasone

Pathobiology

Volumn 71, Issue 1, 2004, Pages 35-42

  Myers, Michael J ^a   Farrell, Dorothy E ^a   Snider III, T G Ron ^b   Post, Lynn O ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Actinobacillus pleuropneumoniae; IL 10; IL 1 ; IL 6; IL 8; Pneumonia; Swine; TNF

Indexed keywords

CYTOKINE; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; LUNG EDEMA; LUNG WEIGHT; NONHUMAN; PLEURA EMPYEMA; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SWINE; TISSUE NECROSIS;

ACTINOBACILLUS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; MYCOPLASMA; SUS SCROFA;

EID: 0141924156     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072960     Document Type: Article

References (46)

1. Nicolet J: Actinobacillus pleuropneumoniae; in Straw BE (ed): Diseases of Swine, ed 8. Ames, Iowa State University Press, 1994, pp 401-407.
2. Shope RE: Porcine contagious pleuropneumonia. 1. Experimental transmission, etiology, and pathology. J Exp Med 1964;1119:357-368.
3. Greenway JA: Haemophilus pneumonia in B.C. swine. Can Vet J 1981;22:20-21.
4. Rosendal S, Boyd DA: Haemophilus pleuropneumoniae serotyping. J Clin Microbiol 1982;16:840-843.
5. Sebunya TNK, Saunders JK: Haemophilus pleuropneumoniae infection in swine: A review. J Am Vet Med Assoc 1983;182:1331-1337.
6. Jacobsen MJ, Nielsen JP, Nielsen R: Comparison of virulence of different Actinobacillus pleuropneumoniae serotypes and biotypes using an aerosol infection model. Vet Microbiol 1996;49:159-168.
7. Idris UE, Harmon BG, Udeze FA, Kadis S: Pulmonary lesions in mice inoculated with Actinobacillus pleuropneumoniae hemolysin and lipopolysaccharide. Vet Pathol 1993;30:234-241.
8. Huang H, Potter AA, Campos M, Leighton FA, Willson PJ, Yates WDG: Pathogenesis of porcine Actinobacillus pleuropneumoniae. 1. Effects of surface components of Actinobacillus pleuropneumoniae in vitro and in vivo. Can J Vet Res 1998;62:93-101.
9. Kamp EM, Stockhofe-Zurwieden N, van Leengoed LAMG, Smits MA: Endobronchial inoculation with Apx toxins of Actinobacillus pleuropneumoniae leads to pleuropneumoniae in pigs. Infect Immun 1997;65:4350-4354.
10. Tasćon RI, Váquez-Boland JA, Gutiérrez-Martin CB, Rodríguez-Barbosa JI, Rodríguez-Ferri EF: Virulence factors of the swine pathogen Actinobacillus pleuropneumoniae. Microbiologia 1996;12:171-184.
11. Haesebrouck F, Chiers K, Van Overbeke I, Ducatelle R: Actinobacillus pleuropneumoniae infections in pigs: The role of virulence factors in pathogenesis and protection. Vet Microbiol 1997;58:239-249.
12. Nakajima Y, Momotano E, Takahashi H, Ishikawa Y, Ito T, Kanesaki M, Madarame H: Endogenous tumor necrosis factor (TNF) production and modification of pathological lesions in experimental Escherichia coli endotoxemia of piglets. Vet Immunol Immunopathol 1995;45:45-54.
13. Faffe DS, Seidl VR, Chagas PS, Goncalves de Morae VL, Capelozzi VL, Rocco PR, Zin WA: Respiratory effects of lipopolysaccharide-induced inflammatory lung injury in mice. Eur Respir J 2000;15:85-91.
14. Takashima K, Tateda K, Matsumoto T, Iizawa Y, Nakao M, Yamaguchi K: Role of tumor necrosis factor-α in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 1997;65:257-260.
15. Udeze FA, Latimer KS, Kadis S: Role of Haemophilus pleuropneumoniae lipopolysaccharide endotoxin in the pathogenesis of porcine Haemophilus pleuropneumonia. Am J Vet Res 1987;48:768-773.
16. Baarsch MJ, Scamurra RW, Burger K, Foss DL, Maheswaran SK, Murtaugh MP: Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae. Infect Immun 1995;63:3587-3594.
17. Choi C, Kwon D, Min K, Chae C: In-situ hybridization for the detection of inflammatory cytokines (IL-1, TNF-alpha and IL-6) in pigs naturally infected with Actinobacillus pleuropneumoniae. J Comp Pathol 1999;121:349-356.
18. Cho W-S, Chae C: Expression of nitric oxide 2 and tumor necrosis factor-α in swine naturally infected with Actinobacillus pleuropneumoniae. Vet Pathol 2002;39:27-32.
19. Huang H, Potter AA, Campos M, Leighton FA, Willson PJ, Haines DM: Pathogenesis of porcine Actinobacillus pleuropneumoniae. 2. Roles of proinflammatory cytokines. Can J Vet Res 1999;63:69-78.
20. Myers MJ, Baarsch MJ, Murtaugh MP: Effects of pentoxifylline on inflammatory cytokine expression and acute pleuropneumonia in swine. Immunobiology 2002;205:17-34.
21. Fossum C, Wattrang E, Fuxler L, Jensen KT, Wallgren P: Evaluation of various cytokines (IL-6, IFN-α, IFN-γ, TNF-α) as markers for acute bacterial infection in swine - A possible role for serum interleukin-6. Vet Immun Immunopathol 1998;64:161-172.
22. Wattrang E, Wallgren P, Fossum C: Actinobacillus pleuropneumoniae serotype 2 - Effects on the interferon-α production of porcine leukocytes in vivo and in vitro. Comp Immunol Microbiol Infect Dis 1998;21:135-154.
23. Hurme M, Siljander P, Anttila H: Regulation of interleukin-1β production by glucocorticoids in human monocytes: The mechanism of action depends on the activation signal. Biochem Biophys Res Commun 1991;180:1383-1389.
24. Hartman DA, Ochalski SJ, Carlson RP: The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A. Inflamm Res 1995;44:269-274.
25. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP: Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications. Proc Assoc Am Physicians 1996;108:374-381.
26. Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche J, Geenen V: Tumor necrosis factor-α decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: Potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999;84:2834-2839.
27. Baarsch MJ, Foss DL, Murtaugh MP: Pathophysiologic correlates of acute porcine pleuropneumonia. Am J Vet Res 2000;61:684-690.
28. Post LO, Cope CV, Farrell DE, Baker JD, Myers MJ: Influence of porcine Actinobacillus pleuropneumoniae (APP) infection and dexamethasone on the pharmacokinetic parameters of enrofloxacin. J Pharmacol Exp Ther 2002;301:217-222.
29. Myers MJ, Farrell DE, Baker JD, Evock-Clover CM, Steele NC: Endotoxin challenge differentially affects cytokine production and metabolic status of growing and finishing swine. Domest Anim Endocrinol 1999;17:345-360.
30. Beutler B, Tkacenko V, Milsark I, Krochin N, Cerami A: Effect of γ-interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype. J Exp Med 1986;164:1791-1796.
31. Myers MJ, Farrell DE, Palmer DC, Post LO: Inflammatory mediator production in swine following endotoxin challenge with or without co-administration of dexamethasone. Int Immunopharmacol 2003;3:571-579.
32. Balaji R, Wright KJ, Turner JL, Hill CM, Dritz SS, Fenwick B, Carrol JA, Zannelli ME, Beausang LA, Minton JE: Circulating cortisol, tumor necrosis factor-α, interleukin-1β, and interferon-γ in pigs infected with Actinobacillus pleuropneumoniae. J Anim Sci 2002;80:202-207.
33. Balaji R, Wright KJ, Turner JL, Hill CM, Dritz SS, Knoppel EL, Minton JE: Acute phase responses of pigs challenged orally with Salmonella typhimurium. J Anim Sci 2000;78:1885-1891.
34. Baker RW, Walker BR, Shaw RJ, Honour JW, Jessop DS, Lightman SL, Zumla A, Rook GAW: Increased cortisol: Cortisone ratio in acute pulmonary tuberculosis. Am J Respir Crit Care Med 2000;162:1641-1647.
35. Wallgren P, Wilen IL, Fossum C: Influence of experimentally induced endogenous production of cortisol on the immune capacity in swine. Vet Immun Immunopathol 1994;42:301-306.
36. McGuinness OP: The impact of infection on glucogeneogenesis in the conscious dog. Shock 1994;2:336-343.
37. Bornstein SR, Preas HL, Chrousos GP, Suffredini AF: Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans. J Infect Dis 1998;178:887-890.
38. Schreiber W, Pollmacher T, Fassbender K, Gudewill S, Wedder H, Weidemann K, Galanos C, Holsboer F: Endotoxin- and corticotropin-releasing hormone-induced release of ACTH and cortisol. A comparative study in men. Neuroendocrinology 1993;58:123-128.
39. Leininger MT, Protocarrero CP, Schinckel AP, Spurlock ME, Bidwell CA, Nielsen JN, Houseknecht KL: Physiological response to acute endotoxemia in swine: Effect of genotype on energy metabolites and leptin. Domest Anim Endocrinol 2000;18:71-82.
40. Elsasser TH, Fayer R, Rumsey TS, Hartnell GF: Recombinant bovine somatotropin blunts plasma tumor necrosis factor-α, cortisol, and thromboxane-B2 responses to endotoxin in vivo. Endocrinology 1994;134:1082-1088.
41. Sapolsky RM, Romero LM, Munck AU: How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89.
42. Yi ES, Remick DG, Lim Y, Tang W, Nadzienko CE, Bedoya A, Yin S, Ulrich TR: The intratracheal administration of endotoxin. 10. Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo. Inflammation 1996;20:165-175.
43. Moreland JG, Fuhrman RM, Wohlford-Leane CL, Quinn TJ, Benda E, Pruessner JA, Schwartz DA: TNF-α and IL-1β are not essential to the inflammatory response in LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 2001;280:73-80.
44. Tang G, White JE, Lumb PD, Lawrence DA, Tsan MF: Role of endogenous cytokines in endotoxin- and interleukin-1-induced pulmonary inflammatory response and oxygen tolerance. Am J Respir Cell Mol Biol 1995;12:339-344.
45. Morrison DF, Foss DL, Murtaugh MP: Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia. Infect Immun 2000;30:4752-4758.
46. Baarsch MJ, Wannemuehler MJ, Molitor TW, Murtaugh MP: Detection of tumor necrosis factor-α from porcine alveolar macrophages using an L929 fibroblast bioassay. J Immunol Methods 1991;140:15-22.